Name | 2-(3,4-Dichlorophenyl)-N-[4-(1,2-oxazol-3-ylsulfamoyl)phenyl]acetamide |
---|---|
Synonyms | Benzeneacetamide, 3,4-dichloro-N-[4-[(3-isoxazolylamino)sulfonyl]phenyl]- |
Description | ML251, a potent nanomolar T. brucei and T. cruzi phosphofructokinase (PFK) inhibitor, inhibits T. brucei PFK (IC50=0.37 μM) and T. cruzi PFK (IC50=0.13 μM). ML251 can be used for the research of parasite[1]. |
---|---|
Related Catalog | |
Target |
IC50: 0.37 μM (T. brucei PFK)[1]. IC50: 0.13 μM (T. cruzi PFK)[1] |
In Vitro | ML251 (T. brucei; 0~33.3 μg/mL) produces modest dose-dependent toxicity[1]. Cell Cytotoxicity Assay[1] Cell Line: T. brucei Concentration: 0~33.3 μg/mL Incubation Time: Result: Dose-dependent reduction of cell viability. |
References |
Density | 1.6±0.1 g/cm3 |
---|---|
Molecular Formula | C17H13Cl2N3O4S |
Molecular Weight | 426.27 |
Exact Mass | 425.000366 |
LogP | 3.61 |
Index of Refraction | 1.669 |